531592 GENPHARMA

Genpharmasec Share Price

₹2.28 +0.03 (1.33%)

13 Feb, 2025 03:18

SIP TrendupStart SIP in GENPHARMA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -25.97%
  • Over 3 Month -22.71%
  • Over 6 Month + 3.64%
  • Over 1 Year -50.76%
SIP Lightning

Smart Investing Starts Here Start SIP with Genpharmasec for Steady Growth!

Invest Now

Genpharmasec Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Genpharmasec Financials

Genpharmasec Technicals

EMA & SMA

Current Price
₹2.28
+ 0.03 (1.33%)
pointer
  • stock-down_img
  • Bearish Moving Average 15
  • stock-up_img
  • Bullish Moving Average 1
  • 20 Day
  • ₹2.53
  • 50 Day
  • ₹2.80
  • 100 Day
  • ₹2.90
  • 200 Day
  • ₹2.88

Resistance and Support

2.26 Pivot Speed
  • R3 2.41
  • R2 2.36
  • R1 2.31
  • S1 2.21
  • S2 2.16
  • S3 2.11

What's your outlook on Genpharmasec?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Genpharmasec has an operating revenue of Rs. 29.91 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genpharmasec Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-10 Quarterly Results
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-06-27 A.G.M.
2024-05-24 Audited Results

Genpharmasec F&O

Genpharmasec Shareholding Pattern

29.98%
0%
59.62%
10.4%

About Genpharmasec

  • NSE Symbol
  • GENPHARMA
  • BSE Symbol
  • 531592
  • ISIN
  • INE861N01036

Similar Stocks to Genpharmasec

Genpharmasec FAQs

Genpharmasec share price is ₹2 As on 13 February, 2025 | 03:04

The Market Cap of Genpharmasec is ₹126.2 Cr As on 13 February, 2025 | 03:04

The P/E ratio of Genpharmasec is 47.4 As on 13 February, 2025 | 03:04

The PB ratio of Genpharmasec is 2 As on 13 February, 2025 | 03:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23